We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medical Solutn | LSE:MLS | London | Ordinary Share | GB0009739649 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.72 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSBS
RNS Number : 6798E
Source BioScience PLC
05 November 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 1. Identity of the issuer or the Source BioScience plc underlying issuer of existing shares to which voting rights are attached: (ii) -------------------------------------- ---------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------- An acquisition or disposal of voting rights ü ----------------------------------------------------------------- ------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------------------------- ------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ----------------------------------------------------------------- ------------ An event changing the breakdown of voting rights ----------------------------------------------------------------- ------------ Other (please specify): ----------------- ---------------------------------------------- ------------ 3. Full name of person(s) subject CHARIOT FUND - SPARTAN FUND LTD. to the notification obligation: SAC CLASS B (iii) ------------------------------------ --------------------------------- 4. Full name of shareholder(s) CHARIOT FUND - SPARTAN FUND LTD. (if different from 3.): (iv) SAC CLASS B ------------------------------------ --------------------------------- 5. Date of the transaction and 21 October 2015 date on which the threshold is crossed or reached: (v) ------------------------------------ --------------------------------- 6. Date on which issuer notified: 4 November 2015 ------------------------------------ --------------------------------- 7. Threshold(s) that is/are crossed Over 3% or reached: (vi, vii) ------------------------------------ --------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------- ------------------------ ------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights -------------- ----------- ----------- ----------- ---------------------- ------------------ Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ----------- ----------- ----------- ----------- --------- ------- --------- GB0009739649 16,021,429 16,021,429 17,491,429 17,491,429 N/A 5.01% N/A -------------- ----------- ----------- ----------- ----------- --------- ------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion rights that rights Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ------------- -------------- ----------------------- ------------ N/A ------------------ ------------- -------------- ----------------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- N/A Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 17,491,429 5.01% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------- N/A --------------------------------------------------------------------------- Proxy Voting: ------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------ ----- 11. Number of voting rights proxy N/A holder will cease to hold: ------------------------------------ ----- 12. Date on which proxy holder will N/A cease to hold voting rights: ------------------------------------ ----- 13. Additional information: N/A ------------------------------ ----- 14. Contact name: N/A ------------------------------ ----- 15. Contact telephone number: N/A ------------------------------ ----- Note: Annex should only be submitted to the FCA not the issuer Annex: Notification of major interests in share A: Identity of the persons or legal entity subject to the notification obligation -------------------------------------------------------------------------------- Full name CHARIOT FUND, SPARTAN FUND LTD. (including legal form of legal SAC CLASS B entities) ------------------------------------ ------------------------------------------ Contact address Equity Trust House, Caves Village (registered office for legal West Bay Street Nassau, Bahamas entities) N-10697 ------------------------------------ ------------------------------------------ Phone number & email +1 (242) 676-8188 mdean@equitybahamas.com ------------------------------------ ------------------------------------------ Other useful information Michael Dean, Vice President Investment (at least legal representative Funds Services for legal persons) ------------------------------------ ------------------------------------------ B: Identity of the notifier, if applicable -------------------------------------------------------------------------------- Full name ------------------------------------------- ----------------------------------- Contact address ------------------------------------------- ----------------------------------- Phone number & email ------------------------------------------- ----------------------------------- Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) ------------------------------------------- ----------------------------------- C: Additional information -------------------------------------------------------------------------------- For notes on how to complete form TR-1 please see the FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGGWPGUPAGUA
(END) Dow Jones Newswires
November 05, 2015 05:27 ET (10:27 GMT)
1 Year Medical Solutions Chart |
1 Month Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions